clinical trial · NCT04557280
A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects
Viatris Innovation GmbH·phase1·completed·n = 24
Healthy SubjectsSelatogrelSelatogrel
brief summary
The main purpose is to study the pharmacokinetics of selatogrel (ACT-246475) using different administration modes and formulations. The clinical pharmacology data will be used to support demonstration of bioequivalence and interchangeability of the different formulations.
started
Nov 6, 2020
primary completion
Dec 19, 2020
completion
Dec 19, 2020
last updated
Jul 3, 2025
official title
A Randomized, Open-label, 3-period Cross-over Study to Assess the Pharmacokinetics of Selatogrel (ACT-246475) in Healthy Subjects After Subcutaneous Administration by Syringe and Auto-injector
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol